Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activitySauveur-Michel Maira, Carlos García-Echeverría, Josef Brueggen et al.|Molecular Cancer Therapeutics|2008Cited by 1.1k
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer modelsMichael Rugaard Jensen, Patrick Chêne|Breast Cancer Research|2008Cited by 224
Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analoguePatrick Chêne, Thomas Radimerski|BMC Chemical Biology|2009Cited by 81
Effect of the acylation of TEAD4 on its interaction with co‐activators YAP and TAZYannick Mesrouze, Patrick Chêne|Protein Science|2017Cited by 69